Course handouts are now available
Click here
Come to London
WATCH to find out why
Site updates:
Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.
Retropupillary iris claw intraocular lens for the surgical correction of aphakia in cases with microspherophakia
(results will display both Free Papers & Poster)
Session Details
Session Title: Cataract Surgery Special Cases I
Session Date/Time: Sunday 14/09/2014 | 14:30-16:30
Paper Time: 15:32
Venue: Boulevard G
First Author: : M.Al-aswad EGYPT
Co Author(s): : B. Ibrahim
Abstract Details
Purpose:
To evaluate safety and recovery of retropupillary fixation of iris-claw intraocular lens (IOL) (Verisyse PMMA IOL, Abbott Medical Optics [AMO], Netherland) in surgical correction of aphakia in microspherophakic eyes where there is no sufficient capsular support
Setting:
Zagazig University Hospital in Sharkia Governorate in Egypt
Methods:
Prospective interventional non comparative case series. This interventional case series comprised 17 eyes of 9 microspherophakic patients. Retropupillary fixation of the Verisyse iris claw IOL [AMO] was done in all cases. Surgical time was measured. Corrected distance visual acuity (CDVA), astigmatism, intraocular pressure, tissue reaction, pigment dispersion and stability of IOL were studied 1 day, 3 days, 1 week , 2 weeks, and 1 and 6 months postoperatively.
Results:
Eight patients had familial microspherophakia and one patient had Marfan's syndrome. 82% of the cases achieved visual acuity of 6/18 or better. There was no significant change in astigmatism postoperatively. There was no significant inflammatory reaction. Transient elevation of IOP was recorded in two cases in the first week only; One IOL developed iris dis-insertion of one of the haptics and was successfully re-inserted. All the other IOLs were well centered and stable. Mean surgical time of Verisyse IOL [AMO] implantation was (18.0 ± 4.5 min)
Conclusions:
Retropupillary fixation of an iris-claw IOL is a safe and effective procedure, provides early visual recovery, and is a time-saving method for correcting aphakia in microspherophakic eyes without sufficient capsular support
Financial Interest:
NONE